Hahaha better not take to much time- many companies are out of the "preclinical stage" and in actual development of medicines. All that press release says is the same thing we already knew and have known- they are looking at this TAT pathway to exploit. Thats great, thats wonderful but dr bob needs to lay down the pipe n get to work. Hes not the only scientist who is working w cannabinoids.
Cannabinoids work and are obviously vital to our biological system or we would not have an endocannabinoid system to begin with- however what doesnt work is someone like Dabney n Melamede selling stock on that fact. Its been years, if they are in this european union or group in amsterdam work could have already begun- it should be preclinical. The methods are there, the medicine is there. They are no synthesizing these compounds in a lab like GW, they are supposedly using natural cannabinoids- so whats the hold up.
Israel is having no issue administering cannabis based meds to patients- theyve been collecting data for years.
87 million spent in 7 yrs, 24 million in the last two- how much was on actual research? Not a single dime- look at the 10k. Professional and administrative fees- ie their paychecks. Dr bob works at cu, universities like Ole Miss have full medical marijuana facilities- why isnt dr bob there? Why doesnt cu have one of these labs? It is legal there
And as for the harvard lawyer being a creep- look at the pictures hes posted of himself. If thats not a creep idk what a creep is i guess. And notice he is barely 30 w no real world experience (other than obviously liking to smoke) hes not a veteran, hes a newbie
